Supplemental Table S1. Efficacy of JAK1 inhibitors and dupilumab.
收藏doi.org2025-01-16 收录
下载链接：
http://doi.org/10.17632/6436c9h74p.1
下载链接
链接失效反馈官方服务：
资源简介：
EASI, Eczema Area and Severity Index; EASI-50/75: improvement of at least 50%/75% in the EASI score compared to baseline; IGA, Investigator's Global Assessment; IQR, interquartile range; JAK, Janus kinase 1; SCORAD, SCORing Atopic Dermatitis; WP-NRS, Weekly Peak Pruritus Numeric Rating Scale.
Continuous variables are presented as median [IQR], and categorical variables are presented as counts (percentages). Data missing: 1 n=14; 2 n=7.
EASI（湿疹面积和严重度指数）；EASI-50/75：与基线相比，EASI评分至少改善50%/75%；IGA（研究者总体评估）；IQR（四分位数间距）；JAK（Janus激酶1）；SCORAD（特应性皮炎评分）；WP-NRS（每周峰值瘙痒数值评分量表。连续变量以中位数[四分位数间距]呈现，分类变量以计数（百分比）呈现。数据缺失：1 n=14；2 n=7。
提供机构：
Mendeley Data
